Siloton Wins £8.4 Million Innovate UK Contract for Quantum Eye Imaging
AI-summarised brief · reviewed before publication
Siloton, a Bristol‑based med‑tech start‑up, has been awarded an £8.4 million, two‑year Innovate UK contract to fast‑track development of its handheld GiraffeOCT retinal imaging system. The funding will support creation of both in‑clinic and at‑home versions, with clinical trials to be run at Sunderland Specialist Eye Hospital and economic analysis by the York Health Economics Consortium. Siloton expects the grant to cut the product timeline by up to two years, enable UK‑based manufacturing, and grow its staff to 16 by August 2028 across photonics, electronics and software roles. The project also underpins a planned raise of capital and the CheetahOCT device, aimed at broader retinal disease detection. The initiative aligns with the UK’s National Quantum Strategy to bring diagnostics into community care.
💡 Why It Matters
- · Miniaturising OCT onto a coin‑sized chip could move eye‑care out of hospitals, directly easing the NHS’s huge retinal‑clinic backlog.